Next, because we expected that p16ink4a expression affects the formation of amyloid plaques by influencing microglial aging, we tested whether p16ink4a expression was increased in brain tissue from patients with AD (Suppl. The gene discussed is CDKN2A; the disease is Alzheimer disease.